MCMINN RACHEL (Chief Executive Officer) sold 0.2% of their position (3.35K shares) of NEUROGENE INC. on the open market
Open‑market sale worth $74.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/30/2026ACC: 0001606302-26-000005
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-3.35K
Net shares
Net seller
$74.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.35K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.35K
Price / share
$22.07
Trade value
$74K
% of position
0.2%
3/26/2026
1.35M→1.34M
Total
Net shares
−3.35K
Net value
-$74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2026 | S · Sale | −3.35K | $22.07 | $74K | 0.2% | 1.35M | 1.34M |
| Total | −3.35K | -$74K | ||||||
Derivative Transactions0
No derivative transactions reported